Bart Degrève

619 total citations
23 papers, 516 citations indexed

About

Bart Degrève is a scholar working on Epidemiology, Genetics and Molecular Biology. According to data from OpenAlex, Bart Degrève has authored 23 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 14 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Bart Degrève's work include Herpesvirus Infections and Treatments (14 papers), Virus-based gene therapy research (13 papers) and Cytomegalovirus and herpesvirus research (7 papers). Bart Degrève is often cited by papers focused on Herpesvirus Infections and Treatments (14 papers), Virus-based gene therapy research (13 papers) and Cytomegalovirus and herpesvirus research (7 papers). Bart Degrève collaborates with scholars based in Belgium, United Kingdom and Sweden. Bart Degrève's co-authors include Erik De Clercq, Jan Balzarini, Jan Balzarini, Anna Karlsson, Magnus Johansson, Robert Esnouf, An R. Van Rompay, Johan Neyts, Graciela Andreï and Lieve Naesens and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

Bart Degrève

23 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bart Degrève Belgium	14	308	189	169	90	89	23	516
Paul J. Hippenmeyer United States	13	351 1.1×	136 0.7×	83 0.5×	66 0.7×	84 0.9×	21	620
Stephanie Drake United States	10	192 0.6×	165 0.9×	129 0.8×	102 1.1×	80 0.9×	14	440
Cécile Artaud United States	14	358 1.2×	51 0.3×	95 0.6×	56 0.6×	55 0.6×	19	590
Teodor‐D. Brumeanu United States	18	227 0.7×	85 0.4×	89 0.5×	30 0.3×	85 1.0×	35	718
Claudia Denk Germany	13	606 2.0×	302 1.6×	204 1.2×	26 0.3×	259 2.9×	15	886
Silvia Valensin Italy	13	346 1.1×	57 0.3×	51 0.3×	44 0.5×	113 1.3×	22	659
Jorge G. Gómez-Gutiérrez United States	17	354 1.1×	139 0.7×	261 1.5×	47 0.5×	229 2.6×	38	688
Dean O. Campbell United States	14	334 1.1×	43 0.2×	89 0.5×	26 0.3×	172 1.9×	19	610
Cornelia Oetke United Kingdom	10	278 0.9×	73 0.4×	86 0.5×	76 0.8×	31 0.3×	10	520
Evelyn W. Wang United States	8	567 1.8×	195 1.0×	61 0.4×	17 0.2×	185 2.1×	8	845

Countries citing papers authored by Bart Degrève

Since Specialization

Citations

This map shows the geographic impact of Bart Degrève's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Degrève with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Degrève more than expected).

Fields of papers citing papers by Bart Degrève

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Degrève. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Degrève. The network helps show where Bart Degrève may publish in the future.

Co-authorship network of co-authors of Bart Degrève

This figure shows the co-authorship network connecting the top 25 collaborators of Bart Degrève. A scholar is included among the top collaborators of Bart Degrève based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Degrève. Bart Degrève is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Rong, Ling Li, Bart Degrève, et al.. (2005). Behavior of Thymidylate Kinase toward Monophosphate Metabolites and Its Role in the Metabolism of 1-(2′-Deoxy-2′-Fluoro-β- l -Arabinofuranosyl)-5-Methyluracil (Clevudine) and 2′,3′-Didehydro-2′,3′-Dideoxythymidine in Cells. Antimicrobial Agents and Chemotherapy. 49(5). 2044–2049. 22 indexed citations

Bird, Louise E., Jingshan Ren, A.S. Wright, et al.. (2003). Crystal Structure of Varicella Zoster Virus Thymidine Kinase. Journal of Biological Chemistry. 278(27). 24680–24687. 23 indexed citations

Degrève, Bart, Chaoyong Zhu, Elisa Durini, et al.. (2001). 2′-O-Acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase. Biochemical Pharmacology. 61(6). 727–732. 13 indexed citations

Clercq, Erik De, Graciela Andreï, Robert Snoeck, et al.. (2001). ACYCLIC/CARBOCYCLIC GUANOSINE ANALOGUES AS ANTI-HERPESVIRUS AGENTS. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 271–285. 54 indexed citations

Degrève, Bart, Robert Esnouf, Erik De Clercq, & Jan Balzarini. (2001). Mutation of Gln125 to Asn Selectively Abolishes the Thymidylate Kinase Activity of Herpes Simplex Virus Type 1 Thymidine Kinase. Molecular Pharmacology. 59(2). 285–293. 11 indexed citations

Grignet‐Debrus, Christine, Nathalie Baudson, Bart Degrève, et al.. (2000). Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-β-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase. Cancer Gene Therapy. 7(2). 215–223. 11 indexed citations

Balzarini, Jan, Bart Degrève, Robert Esnouf, et al.. (2000). Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase. FEBS Letters. 483(2-3). 181–185. 33 indexed citations

Degrève, Bart, Erik De Clercq, & Jan Balzarini. (2000). Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and ganciclovir (GCV). Gene Therapy. 7(18). 1543–1552. 7 indexed citations

Balzarini, Jan, Bart Degrève, Sigrid Hatse, et al.. (2000). The Multifunctional Deoxynucleoside Kinase of Insect Cells Is a Target for the Development of New Insecticides. Molecular Pharmacology. 57(4). 811–819. 9 indexed citations

10.

Degrève, Bart, Robert Esnouf, Erik De Clercq, & Jan Balzarini. (2000). Selective Abolishment of Pyrimidine Nucleoside Kinase Activity of Herpes Simplex Virus Type 1 Thymidine Kinase by Mutation of Alanine-167 to Tyrosine. Molecular Pharmacology. 58(6). 1326–1332. 22 indexed citations

11.

Degrève, Bart, Erik De Clercq, Anna Karlsson, & Jan Balzarini. (1999). Efficacy of antiherpetic drugs in combined gene/chemotherapy of cancer is not affected by a specific nuclear or cytoplasmic compartmentation of herpes thymidine kinases. 3. 1 indexed citations

12.

Johansson, Magnus, An R. Van Rompay, Bart Degrève, Jan Balzarini, & Anna Karlsson. (1999). Cloning and Characterization of the Multisubstrate Deoxyribonucleoside Kinase of Drosophila melanogaster. Journal of Biological Chemistry. 274(34). 23814–23819. 83 indexed citations

13.

Degrève, Bart, Robert Esnouf, Erik De Clercq, & Jan Balzarini. (1999). Characterization of Multiple Nuclear Localization Signals in Herpes Simplex Virus Type 1 Thymidine Kinase. Biochemical and Biophysical Research Communications. 264(2). 338–342. 15 indexed citations

14.

Wera, Stefaan, Bart Degrève, Jan Balzarini, et al.. (1999). Budding Yeast as a Screening Tool for Discovery of Nucleoside Analogs for Use in HSV-1 TK Suicide-Gene Therapy. BioTechniques. 27(4). 772–777. 3 indexed citations

15.

Hatse, Sigrid, Lieve Naesens, Bart Degrève, et al.. (1998). Potent antitumor activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine in choriocarcinoma-bearing rats. International Journal of Cancer. 76(4). 595–600. 25 indexed citations

16.

Hatse, Sigrid, Lieve Naesens, Bart Degrève, et al.. (1998). In Vitro and in Vivo Inhibitory Activity of the Differentiation-Inducing Agent 9-(2-Phosphonylmethoxyethyl)Adenine (Pmea) Against Rat Choriocarcinoma. Advances in experimental medicine and biology. 431. 605–609. 2 indexed citations

17.

Balzarini, Jan, Bart Degrève, Graciela Andreï, et al.. (1998). Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells. Gene Therapy. 5(3). 419–426. 23 indexed citations

18.

Degrève, Bart, Magnus Johansson, Erik De Clercq, Anna Karlsson, & Jan Balzarini. (1998). Differential Intracellular Compartmentalization of Herpetic Thymidine Kinases (TKs) in TK Gene-Transfected Tumor Cells: Molecular Characterization of the Nuclear Localization Signal of Herpes Simplex Virus Type 1 TK. Journal of Virology. 72(12). 9535–9543. 42 indexed citations

19.

Degrève, Bart, Graciela Andreï, Manuel Izquierdo, et al.. (1997). Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer. Gene Therapy. 4(10). 1107–1114. 35 indexed citations

20.

Liekens, Sandra, Johan Neyts, Bart Degrève, & Erik De Clercq. (1997). The sulfonic acid polymers PAMPS [poly(2-acrylamido-2-methyl-1-propanesulfonic acid)] and related analogues are highly potent inhibitors of angiogenesis.. PubMed. 9(4). 173–81. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact